Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Celldex Therapeutics, Inc.    

CELLDEX THERAPEUTICS, INC.

 SummaryChartsNewsCalendarCompany 
Company
Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. Its lead drug Rintega (also referred to as rindopepimut and CDX-110) is a therapeutic... 
Sector
Biotechnology & Medical Research
Calendar
11/06 | 04:45pmPresentation
More about the company
Latest news on CELLDEX THERAPEUTICS, INC.
10/02Celldex Therapeutics Announces Upcoming Data Presentations
GL
09/30Celldex Therapeutics to Present at the Cantor Global Healthcare Conference
GL
08/07CELLDEX : 2Q Earnings Snapshot
AQ
08/07CELLDEX THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
08/07CELLDEX THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
08/07CELLDEX THERAPEUTICS : Provides Corporate Update and Reports Second Quarter 2019..
AQ
07/31Celldex to Report Second Quarter 2019 Financial Results and Host Corporate Up..
GL
06/24CELLDEX THERAPEUTICS, INC. : Change in Directors or Principal Officers, Regulati..
AQ
06/24Celldex Therapeutics Appoints Diane C. Young, M.D. as Senior Vice President, ..
GL
06/20CELLDEX THERAPEUTICS, INC. : Change in Directors or Principal Officers, Submissi..
AQ
06/01Celldex Announces Data from CDX-3379 Clinical Program Presented at ASCO 2019;..
GL
05/10CELLDEX THERAPEUTICS : Continues to Stretch Out Its Cash and Advance Its Pipelin..
AQ
05/07CELLDEX : 1Q Earnings Snapshot
AQ
05/07CELLDEX THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
05/07CELLDEX THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
More news
News in other languages on CELLDEX THERAPEUTICS, INC.
02/11CELLDEX THERAPEUTICS, INC. : REVERSE SPLIT: 1 of 15
02/11CELLDEX THERAPEUTICS, INC. : REVERSE SPLIT: 1 of 15
2017CELLDEX THERAPEUTICS, INC. : Veröffentlichung des Jahresergebnisses
2017CELLDEX THERAPEUTICS, INC. : publication des résultats annuels
2016Wall Street en légère baisse dans les premiers échanges
More news
Analyst Recommendations on CELLDEX THERAPEUTICS, INC.
More recommendations
Sector news : Biotechnology & Medical Research - NEC
04:01pProspects for a Brexit Deal Cheer Businesses, but Big Questions Remain
DJ
08:29aGLOBAL MARKETS LIVE : Nestlé, Netflix, Huawei, General Motors…
10/16INCYTE : Says Phase 3 REACH2 Trial Meets Endpoint
DJ
10/15New Gilead Sciences CFO Expected to Pursue More Deals to Expand Portfolio
DJ
10/15GILEAD SCIENCES : Names Andrew Dickinson Chief Financial Officer
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart CELLDEX THERAPEUTICS, INC.
Duration : Period :
Celldex Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Anthony S. Marucci President, Chief Executive Officer & Director
Karen Lipton Shoos Chairman
Sam Martin CFO, Secretary, Treasurer & Senior Vice President
Tibor Keler Chief Scientific Officer & Executive VP
Diane C. Young Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CELLDEX THERAPEUTICS, INC.2,694.34%36
IQVIA HOLDINGS INC.24.67%28 371
LONZA GROUP32.94%25 332
CELLTRION, INC.--.--%20 127
INCYTE CORPORATION22.85%16 801
SEATTLE GENETICS, INC.48.01%14 251